Le Lézard
Classified in: Health

APACMed Names EVERSANA Knowledge Partner to Shape Digital Health Reimbursement Framework Across Region


SINGAPORE, March 21, 2023 /PRNewswire/ -- Asia Pacific Medical Technology Association (APACMed), the region's leading organization for medical technology manufacturers, has named  EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry and a market leader in helping digital health technology innovators navigate the complexity of bringing new therapies to patients, as its knowledge partner across Asia Pacific countries.

Together, the two organizations will develop a framework to support innovative reimbursement models for digital health companies as they work with policymakers to ensure better access to new and transformative therapies, diagnostic aids and patient management solutions.

"We are excited to welcome EVERSANA as our knowledge partner in the APACMed Digital Health Reimbursement Alliance. With their global expertise and our shared vision for equitable access to life-saving digital health technologies, we will collaborate on building advocacy to shape the future of digital health reimbursement," said Harjit Gill, CEO of APACMed.

The partnership leverages the expertise of both organizations. EVERSANA has seen rapid expansion over the past three years across the Asia Pacific region and is the industry leader in supporting the commercialization of digital health technologies globally. Meanwhile, APACMed is the largest trade association across Asia Pacific and represents more than 300 manufacturers and suppliers of medical equipment and wearable devices.

"Digital innovation is the future of care across so many therapeutic categories with the potential to change how we think of healthcare today," said Jim Lang, CEO of EVERSANA. "We look forward to working with APACMed to leverage our respective expertise to help develop an important framework to drive better access for patients to therapies."

About APACMed

The Asia Pacific Medical Technology Association (APACMed) represents manufacturers and suppliers of medical equipment, devices and in-vitro diagnostics, industry associations and other key stakeholders associated with the medical technology industry in Asia Pacific. As a trade association, our mission is to improve the standards of care for patients through innovative collaborations among stakeholders to jointly shape the future of healthcare in Asia Pacific.

The association has over 300 member organisations made up of multinational corporates, associates, digital technology, and start-up companies. To learn more visit www.apacmed.org.

About EVERSANA®

EVERSANA® is the leading independent provider of global services to the life sciences industry. The company's integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit eversana.com or connect through LinkedIn and Twitter.

MEDIA CONTACTS

Matt Braun, Director, Corporate Communications, EVERSANA
Tel: +1 414-434-4830
E-mail: [email protected]

SOURCE EVERSANA


These press releases may also interest you

at 06:31
Hangzhou Tigermed Consulting Co., Ltd. ("Tigermed" or the "company") (Stock code: 300347.SZ / 3347.HK), a leading global provider of integrated research and development solutions for biopharmaceutical and medical device industry, announced its annual...

at 06:30
Caris Life Sciences®(Caris), the leading next-generation AI TechBio company and precision medicine pioneer that is actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition using molecular...

at 06:30
The collagen water market is booming thanks to the growing popularity of health and beauty products. Consumers are more interested in skincare and healthy eating, which is driving manufacturers to create collagen-infused drinks and cosmetics. A new...

at 06:30
Viavi Solutions Inc. (VIAVI)  today announced it has participated in the 2024 RIC Forum, March 26-28, in Dallas, Texas. The company contributed its TeraVM RIC Test and TM500 Network Tester to multiple demonstrations, building on collaborations at MWC...

at 06:30
Three clinical programs present diversified opportunities in and outside the existing anti-VEGF market and are being progressed toward Phase 3 value inflection points  New Phase 3 GLOW2 study of tarcocimab in diabetic retinopathy actively...

at 06:30
The "PCR Markets. Forecasts for qPCR, dPCR, Singleplex & Multiplex Markets and by Application, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2023 to 2027" report has been added to...



News published on and distributed by: